Zhang JN - Search Results

1

Multi-omics pan-cancer analysis reveals the prognostic values and immunological functions of PPA2, with a spotlight on breast cancer.

Zhang JN, Yang BB, Li LW, Xu H, Wang B, Yi ZL, Zhou XR, Liu H. Zhang JN, et al. Front Immunol. 2024 Aug 8;15:1435502. doi: 10.3389/fimmu.2024.1435502. eCollection 2024. Front Immunol. 2024. PMID: 39176095 Free PMC article.

2

HBV/Pregenomic RNA Increases the Stemness and Promotes the Development of HBV-Related HCC Through Reciprocal Regulation With Insulin-Like Growth Factor 2 mRNA-Binding Protein 3.

Ding WB, Wang MC, Yu J, Huang G, Sun DP, Liu L, Zhang JN, Yang Y, Liu H, Zhou WP, Yang F, Yuan SX. Ding WB, et al. Among authors: zhang jn. Hepatology. 2021 Sep;74(3):1480-1495. doi: 10.1002/hep.31850. Epub 2021 Jul 29. Hepatology. 2021. PMID: 33825218

3

Upregulated KPNA2 promotes hepatocellular carcinoma progression and indicates prognostic significance across human cancer types.

Guo X, Wang Z, Zhang J, Xu Q, Hou G, Yang Y, Dong C, Liu G, Liang C, Liu L, Zhou W, Liu H. Guo X, et al. Acta Biochim Biophys Sin (Shanghai). 2019 Mar 1;51(3):285-292. doi: 10.1093/abbs/gmz003. Acta Biochim Biophys Sin (Shanghai). 2019. PMID: 30883648 Free article.

4

Role of miRNA-99a-5p in Modulating the Function of Hepatocellular Carcinoma Cells: Bioinformatics Analysis and In Vitro Assay.

Zhang JN, Wei F, Zheng BB, Tang L, Chen FY. Zhang JN, et al. Curr Cancer Drug Targets. 2023;23(6):461-470. doi: 10.2174/1568009623666230202155440. Curr Cancer Drug Targets. 2023. PMID: 36733207

5

Expression of m6A RNA Methylation Regulators and Their Clinical Predictive Value in Intrahepatic Cholangiocarcinoma.

Wei F, Zhang JN, Zhao YQ, Lyu H, Chen F. Wei F, et al. Among authors: zhang jn. Front Biosci (Landmark Ed). 2023 Jun 27;28(6):120. doi: 10.31083/j.fbl2806120. Front Biosci (Landmark Ed). 2023. PMID: 37395024 Free article.

6

Cyclin-Dependent Kinase 4 is expected to be a therapeutic target for hepatocellular carcinoma metastasis using integrated bioinformatic analysis.

Zhang JN, Wei F, Lei LH, Yang Y, Yang Y, Zhou WP. Zhang JN, et al. Bioengineered. 2021 Dec;12(2):11728-11739. doi: 10.1080/21655979.2021.2006942. Bioengineered. 2021. PMID: 34784846 Free PMC article.

7

Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma.

Qin X, Zhang J, Lin Y, Sun XM, Zhang JN, Cheng ZQ. Qin X, et al. Among authors: zhang jn, zhang j. J Transl Med. 2020 Aug 28;18(1):326. doi: 10.1186/s12967-020-02494-7. J Transl Med. 2020. PMID: 32859232 Free PMC article.

8

The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma.

Zhang JN, Ding DY, Yang SY, Tao QF, Yang Y, Zhou WP. Zhang JN, et al. Pathol Res Pract. 2022 Aug;236:153989. doi: 10.1016/j.prp.2022.153989. Epub 2022 Jun 17. Pathol Res Pract. 2022. PMID: 35753134 Review.

9

Establishment and validation of lncRNA-related prognostic signatures in cholangiocarcinoma.

Li F, Zhang J, Zhang J, Xue H, Liu L, Yang Z, Dong H, Wang K. Li F, et al. Genomics. 2023 May;115(3):110621. doi: 10.1016/j.ygeno.2023.110621. Epub 2023 Apr 15. Genomics. 2023. PMID: 37068643 Free article.

10

Comparison of Surgical Outcomes Between Separation Surgery and Piecemeal Spondylectomy for Spinal Metastasis: A Retrospective Analysis.

Xu L, Huang W, Cai W, Sun Z, Fang M, Ji Y, Wang S, Zhang J, Hu T, Cheng M, Yan W. Xu L, et al. Front Surg. 2021 Nov 22;8:686930. doi: 10.3389/fsurg.2021.686930. eCollection 2021. Front Surg. 2021. PMID: 34881284 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

585 results

Search Page

Filters